LivaNova (LIVN): are the analysts right?

LivaNova · Health Care · ref. ETF XLV · 51 calls · price $82.58
What the company does: LivaNova PLC conçoit et fabrique des produits et thérapies médicales innovants.
📈 1-year price
$83.58+79.1% over range
Jul 8, 25low $41.13 · high $84.03Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
83% recommend buying · 6 analysts
⚠️ The stock trades above the median target: it has beaten expectations. The “Buy” reflects conviction on the company, but the remaining quantified upside is low/negative.

🎯 Analyst price target on LIVN

High target · 2 analysts$92+11.4%
Median target · 6 analysts$78.5-4.9%
Low target · 1 analyst$70-15.2%
Current price$82.58

🗳️ The analyst consensus

Analyst breakdown · 6 (6 months)
Strong Buy0%
Buy83%
Hold17%
Sell0%
Strong Sell0%

✅ Historical analyst reliability on LIVN

Most reliable analysts on LIVN (% profitable · 365j · ≥2 calls)
Baird 100% +24.0% 3
Needham 62% +10.6% 13
Goldman Sachs 50% +27.4% 2
Stifel 50% +26.2% 2
Mizuho 33% -3.2% 6

📊 What $1,000 invested in LivaNova would be worth

In short — $1,000 invested in LivaNova 10 years ago would be worth $1,385 today, i.e. +3%/yr on average. Best year: 2017 (+78%), worst: 2022 (-36%). Price performance, excluding dividends.

If I'd invested $1,000 in LivaNova

InvestmentWorth todayGain
1 years ago$1,776+78%
3 years ago$1,481+48%
5 years ago$1,242+24%
10 years ago$1,385+39%
since inception (2015)$1,374+37%

Return by year (LivaNova)

YearReturn$1,000 invested at year start
2026 (YTD)+34%$1,336 (+34%)
2025+33%$1,776 (+78%)
2024-10%$1,589 (+59%)
2023-7%$1,481 (+48%)
2022-36%$941 (-6%)
2021+32%$1,242 (+24%)
2020-12%$1,090 (+9%)
2019-18%$899 (-10%)
2018+14%$1,029 (+3%)
2017+78%$1,829 (+83%)
2016-24%$1,385 (+39%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on LIVN

Keybanc
Jun 22, 26
▲ Overweight · 🎯$92
Price at call : $78.71 — upside +17%
Today : $82.58 — upside +11%
🎯 on LIVN : no call matured yet · 📊 on Health : 33.3% · -8.8% (42 calls)
in progress (365j)
matures : Jun 22, 27
Barclays
May 7, 26
■ Equal-Weight neutral · not a buy · 🎯$76
Price at call : $71.86 — gap to target +6%
Today : $82.58 — gap to target -8%
🎯 on LIVN : no call matured yet · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : May 7, 27
Mizuho
May 7, 26
▲ Outperform · 🎯$90
Price at call : $70.93 — upside +27%
Today : $82.58 — upside +9%
🎯 on LIVN : 33% (6 calls matureds) · 📊 on Health : 58.2% · +13.7% (55 calls)
in progress (365j)
matures : May 7, 27
Baird
May 7, 26
▲ Outperform · 🎯$76
Price at call : $70.93 — upside +7%
Today : $82.58 — upside -8%
🎯 on LIVN : 100% (3 calls matureds) · 📊 on Health : 48.6% · +2.9% (70 calls)
in progress (365j)
matures : May 7, 27
Barclays
Feb 27, 26
■ Equal-Weight neutral · not a buy · 🎯$73
Price at call : $70.27 — gap to target +4%
Today : $82.58 — gap to target -12%
🎯 on LIVN : no call matured yet · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Feb 27, 27
Needham
Feb 25, 26
▲ Buy · 🎯$81
Price at call : $71 — upside +14%
Today : $82.58 — upside -2%
🎯 on LIVN : 62% (13 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
in progress (365j)
matures : Feb 25, 27
Barclays
Jan 9, 26
■ Equal-Weight neutral · not a buy · 🎯$67
Price at call : $62.38 — gap to target +7%
Today : $82.58 — gap to target -19%
🎯 on LIVN : no call matured yet · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Jan 9, 27
Stifel
Jan 7, 26
▲ Buy · 🎯$70
Price at call : $64.62 — upside +8%
Today : $82.58 — upside -15%
🎯 on LIVN : 50% (2 calls matureds) · 📊 on Health : 47.2% · +12.4% (89 calls)
in progress (365j)
matures : Jan 7, 27
Keybanc
Dec 19, 25
▲ Overweight · 🎯$81
Price at call : $62.82 — upside +29%
Today : $82.58 — upside -2%
🎯 on LIVN : no call matured yet · 📊 on Health : 33.3% · -8.8% (42 calls)
in progress (365j)
matures : Dec 19, 26
Mizuho
Dec 17, 25
▲ Outperform · 🎯$72
Price at call : $63.08 — upside +14%
Today : $82.58 — upside -13%
🎯 on LIVN : 33% (6 calls matureds) · 📊 on Health : 58.2% · +13.7% (55 calls)
in progress (365j)
matures : Dec 17, 26
Mizuho
Nov 13, 25
▲ Outperform · 🎯$70
Price at call : $55.2 — upside +27%
Today : $82.58 — upside -15%
🎯 on LIVN : 33% (6 calls matureds) · 📊 on Health : 58.2% · +13.7% (55 calls)
in progress (365j)
matures : Nov 13, 26
Baird
Nov 13, 25
▲ Outperform · 🎯$70
Price at call : $55.2 — upside +27%
Today : $82.58 — upside -15%
🎯 on LIVN : 100% (3 calls matureds) · 📊 on Health : 48.6% · +2.9% (70 calls)
in progress (365j)
matures : Nov 13, 26
Baird
Nov 6, 25
▲ Outperform · 🎯$63
Price at call : $50.45 — upside +25%
Today : $82.58 — upside -24%
🎯 on LIVN : 100% (3 calls matureds) · 📊 on Health : 48.6% · +2.9% (70 calls)
in progress (365j)
matures : Nov 6, 26
Needham
Sep 3, 25
▲ Buy · 🎯$64
Price at call : $56.59 — upside +13%
Today : $82.58 — upside -22%
🎯 on LIVN : 62% (13 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
in progress (365j)
matures : Sep 3, 26
Barclays
Aug 21, 25
■ Equal-Weight neutral · not a buy · 🎯$58
Price at call : $55.9 — gap to target +4%
Today : $82.58 — gap to target -30%
🎯 on LIVN : no call matured yet · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Aug 21, 26
▲ Outperform · 🎯$60
Price at call : $43.66 — upside +37%
Today : $82.58 — upside -27%
Expected +37% · Actual +69% · Reason (≥ +15%) : ✓ Yes
🎯 on LIVN : 100% (1 call matured) · 📊 on Health : 46.2% · +2.9% (13 calls)
+68.7%
stock +69% · XLV +13%
Needham
May 13, 25
▲ Buy · 🎯$64
Price at call : $44.06 — upside +45%
Today : $82.58 — upside -22%
Expected +45% · Actual +64% · Reason (≥ +15%) : ✓ Yes
🎯 on LIVN : 62% (13 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
+64.4%
stock +64% · XLV +11%
Barclays
May 8, 25
■ Equal-Weight neutral · not a buy · 🎯$55
Price at call : $44.06 — gap to target +25%
Today : $82.58 — gap to target -33%
🎯 on LIVN : no call matured yet · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : May 8, 26
Baird
May 8, 25
▲ Outperform · 🎯$61
Price at call : $44.07 — upside +38%
Today : $82.58 — upside -26%
Expected +38% · Actual +63% · Reason (≥ +15%) : ✓ Yes
🎯 on LIVN : 100% (3 calls matureds) · 📊 on Health : 48.6% · +2.9% (70 calls)
+63.1%
stock +63% · XLV +7%
Needham
Mar 17, 25
▲ Buy · 🎯$64
Price at call : $41.41 — upside +55%
Today : $82.58 — upside -22%
Expected +55% · Actual +51% · Reason (≥ +15%) : ✓ Yes
🎯 on LIVN : 62% (13 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
+50.8%
stock +51% · XLV +2%
Barclays
Mar 7, 25
■ Equal-Weight neutral · not a buy · 🎯$56
Price at call : $39.17 — gap to target +43%
Today : $82.58 — gap to target -32%
🎯 on LIVN : no call matured yet · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Mar 7, 26
▲ Buy · 🎯$55
Price at call : $41.56 — upside +32%
Today : $82.58 — upside -33%
Expected +32% · Actual +57% · Reason (≥ +15%) : ✓ Yes
🎯 on LIVN : 50% (2 calls matureds) · 📊 on Health : 52.2% · +7.8% (90 calls)
+57.0%
stock +57% · XLV +6%
Mizuho
Feb 26, 25
▲ Outperform · 🎯$60
Price at call : $40.93 — upside +47%
Today : $82.58 — upside -27%
Expected +47% · Actual +72% · Reason (≥ +15%) : ✓ Yes
🎯 on LIVN : 33% (6 calls matureds) · 📊 on Health : 58.2% · +13.7% (55 calls)
+72.5%
stock +72% · XLV +9%
Stifel
Feb 26, 25
▲ Buy · 🎯$60
Price at call : $41.45 — upside +45%
Today : $82.58 — upside -27%
Expected +45% · Actual +71% · Reason (≥ +15%) : ✓ Yes
🎯 on LIVN : 50% (2 calls matureds) · 📊 on Health : 47.2% · +12.4% (89 calls)
+71.3%
stock +71% · XLV +6%
Needham
Feb 26, 25
▲ Buy · 🎯$64
Price at call : $41.45 — upside +54%
Today : $82.58 — upside -22%
Expected +54% · Actual +71% · Reason (≥ +15%) : ✓ Yes
🎯 on LIVN : 62% (13 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
+71.3%
stock +71% · XLV +6%
Needham
Jan 28, 25
▲ Buy · 🎯$75
Price at call : $50.53 — upside +48%
Today : $82.58 — upside -9%
Expected +48% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on LIVN : 62% (13 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
+26.5%
stock +26% · XLV +5%
Needham
Nov 25, 24
▲ Buy · 🎯$75
Price at call : $51.75 — upside +45%
Today : $82.58 — upside -9%
Expected +45% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on LIVN : 62% (13 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
+22.3%
stock +22% · XLV +9%
Needham
Nov 12, 24
▲ Buy · 🎯$75
Price at call : $53.58 — upside +40%
Today : $82.58 — upside -9%
Expected +40% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 62% (13 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
+3.0%
stock +3% · XLV +4%
Mizuho
Oct 31, 24
▲ Outperform · 🎯$70
Price at call : $51.13 — upside +37%
Today : $82.58 — upside -15%
Expected +37% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 33% (6 calls matureds) · 📊 on Health : 58.2% · +13.7% (55 calls)
+2.8%
stock +3% · XLV -2%
Baird
Oct 31, 24
▲ Outperform · 🎯$72
Price at call : $51.62 — upside +39%
Today : $82.58 — upside -13%
Expected +39% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 100% (3 calls matureds) · 📊 on Health : 48.6% · +2.9% (70 calls)
+2.0%
stock +2% · XLV -2%
Needham
Oct 31, 24
▲ Buy · 🎯$75
Price at call : $51.62 — upside +45%
Today : $82.58 — upside -9%
Expected +45% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 62% (13 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
+2.0%
stock +2% · XLV -2%
▲ Buy · 🎯$65
Price at call : $53.83 — upside +21%
Today : $82.58 — upside -21%
Expected +21% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 50% (2 calls matureds) · 📊 on Health : 52.2% · +7.8% (90 calls)
-2.2%
stock -2% · XLV -5%
Baird
Sep 17, 24
▲ Outperform · 🎯$66
Price at call : $51 — upside +29%
Today : $82.58 — upside -20%
Expected +29% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 100% (3 calls matureds) · 📊 on Health : 48.6% · +2.9% (70 calls)
+6.9%
stock +7% · XLV -12%
Baird
Aug 28, 24
■ Neutral neutral · not a buy · 🎯$55
Price at call : $50.24 — gap to target +9%
Today : $82.58 — gap to target -33%
🎯 on LIVN : 100% (3 calls matureds) · 📊 on Health : 48.6% · +2.9% (70 calls)
in progress (365j)
matures : Aug 28, 25
Baird
Aug 1, 24
■ Neutral neutral · not a buy · 🎯$55
Price at call : $48.32 — gap to target +14%
Today : $82.58 — gap to target -33%
🎯 on LIVN : 100% (3 calls matureds) · 📊 on Health : 48.6% · +2.9% (70 calls)
in progress (365j)
matures : Aug 1, 25
Needham
Jul 31, 24
▲ Buy · 🎯$75
Price at call : $48.32 — upside +55%
Today : $82.58 — upside -9%
Expected +55% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 62% (13 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
-14.9%
stock -15% · XLV -13%
Stifel
Jul 25, 24
▲ Buy · 🎯$72
Price at call : $53.61 — upside +34%
Today : $82.58 — upside -13%
Expected +34% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 50% (2 calls matureds) · 📊 on Health : 47.2% · +12.4% (89 calls)
-18.9%
stock -19% · XLV -10%
Needham
Jun 6, 24
▲ Buy · 🎯$72
Price at call : $53.38 — upside +35%
Today : $82.58 — upside -13%
Expected +35% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 62% (13 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
-13.3%
stock -13% · XLV -8%
Mizuho
May 2, 24
▲ Buy · 🎯$80
Price at call : $62.92 — upside +27%
Today : $82.58 — upside -3%
Expected +27% · Actual -42% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 33% (6 calls matureds) · 📊 on Health : 58.2% · +13.7% (55 calls)
-41.5%
stock -42% · XLV -1%
Baird
May 2, 24
■ Neutral neutral · not a buy · 🎯$66
Price at call : $62.92 — gap to target +5%
Today : $82.58 — gap to target -20%
🎯 on LIVN : 100% (3 calls matureds) · 📊 on Health : 48.6% · +2.9% (70 calls)
in progress (365j)
matures : May 2, 25
Needham
May 1, 24
▲ Buy · 🎯$72
Price at call : $62.92 — upside +14%
Today : $82.58 — upside -13%
Expected +14% · Actual -42% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 62% (13 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
-41.5%
stock -42% · XLV -1%
Mizuho
Mar 27, 24
▲ Buy · 🎯$75
Price at call : $55.94 — upside +34%
Today : $82.58 — upside -9%
Expected +34% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 33% (6 calls matureds) · 📊 on Health : 58.2% · +13.7% (55 calls)
-30.0%
stock -30% · XLV -2%
Needham
Mar 20, 24
▲ Buy · 🎯$72
Price at call : $56.28 — upside +28%
Today : $82.58 — upside -13%
Expected +28% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 62% (13 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
-29.8%
stock -30% · XLV +1%
Barclays
Feb 27, 24
■ Equal-Weight neutral · not a buy · 🎯$61
Price at call : $55.09 — gap to target +11%
Today : $82.58 — gap to target -26%
🎯 on LIVN : no call matured yet · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Feb 26, 25
Barclays
Feb 26, 24
■ Equal-Weight neutral · not a buy · 🎯$61
Price at call : $55.97 — gap to target +9%
Today : $82.58 — gap to target -26%
🎯 on LIVN : no call matured yet · 📊 on Health : 47.8% · +1.6% (186 calls)
in progress (365j)
matures : Feb 25, 25
Baird
Feb 22, 24
■ Neutral neutral · not a buy · 🎯$62
Price at call : $57.12 — gap to target +9%
Today : $82.58 — gap to target -25%
🎯 on LIVN : 100% (3 calls matureds) · 📊 on Health : 48.6% · +2.9% (70 calls)
in progress (365j)
matures : Feb 21, 25
Mizuho
Feb 22, 24
▲ Buy · 🎯$75
Price at call : $57.12 — upside +31%
Today : $82.58 — upside -9%
Expected +31% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 33% (6 calls matureds) · 📊 on Health : 58.2% · +13.7% (55 calls)
-13.3%
stock -13% · XLV -0%
Needham
Feb 21, 24
▲ Buy · 🎯$72
Price at call : $56.24 — upside +28%
Today : $82.58 — upside -13%
Expected +28% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 62% (13 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
-15.7%
stock -16% · XLV -1%
Mizuho
Feb 20, 24
▲ Buy · 🎯$70
Price at call : $52.6 — upside +33%
Today : $82.58 — upside -15%
Expected +33% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 33% (6 calls matureds) · 📊 on Health : 58.2% · +13.7% (55 calls)
-9.7%
stock -10% · XLV +1%
Needham
Nov 17, 23
▲ Buy · 🎯$62
Price at call : $46.77 — upside +33%
Today : $82.58 — upside -25%
Expected +33% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on LIVN : 62% (13 calls matureds) · 📊 on Health : 45.5% · +1.8% (134 calls)
+12.3%
stock +12% · XLV +11%
HSBC
Sep 6, 23
■ Hold neutral · not a buy · 🎯$52
Price at call : $54.52 — gap to target -5%
Today : $82.58 — gap to target -37%
🎯 on LIVN : no call matured yet · 📊 overall : 38.5% · -3.5% (26 calls)
in progress (365j)
matures : Sep 5, 24
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)